stella
beta
Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer — Stella
Home
/
Immune-related Adverse Event
/
View on ClinicalTrials.gov
Recruiting
Back to Immune-related Adverse Event trials
Trial locations
(1 site)
China
Xijing hospital, Xi'an, Shaanxi